Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.00
+0.60 (4.84%)
Aug 17, 2026, 4:35 PM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 55.69 million as of August 17, 2026. Its market cap has increased by 5.43% in one year.
Market Cap
55.69M
Enterprise Value
47.39M
Revenue
6.00M
Ranking
n/a
PE Ratio
10.51
Stock Price
13.00
ChartMarket Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 55.69M, a decrease of -13.59%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 55.69M | 39.78% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 74.39B |
| Haleon | 31.53B |
| Smith & Nephew | 9.30B |
| Ondine Biomedical | 71.44M |
| ECO Animal Health Group | 68.44M |
| Poolbeg Pharma | 66.42M |
| Kooth | 53.50M |